Anika Therapeutics(us:ANIK)
16.28
-0.18%
Updated on 2024-12-23
Open:16.25
Close:16.28
High:16.56
Low:15.85
Pre Close:16.31
Volume:39173.00
Amount:637909.81
Turnover:0.27%
Shares:14.65M
MarketCap:238.43M
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 122 | 13193167 | 88.91% | 9 | 39 | 60 |
| 2024-03-31 | 126 | 13386217 | 90.32% | 13 | 43 | 51 |
| 2023-12-31 | 136 | 13249027 | 90.38% | 20 | 43 | 61 |
| 2023-09-30 | 143 | 12983151 | 88.70% | 27 | 30 | 72 |
| 2023-06-30 | 128 | 13091954 | 89.32% | 10 | 46 | 51 |
| 2023-03-31 | 131 | 13008896 | 88.25% | 11 | 40 | 59 |
| 2022-12-31 | 137 | 13104938 | 89.61% | 16 | 37 | 63 |
| 2022-09-30 | 132 | 13378565 | 91.59% | 10 | 48 | 55 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-03-31 | Trigran Investments, Inc. | 2072424 | 13.98% | -66630 | -3.12% |
| 2024-03-31 | Blackrock Inc. | 1561112 | 10.53% | 177235 | 12.81% |
| 2024-03-31 | Caligan Partners Lp | 1435993 | 9.69% | 354633 | 32.80% |
| 2024-03-31 | Dimensional Fund Advisors Lp | 809755 | 5.46% | -11697 | -1.42% |
| 2024-03-31 | Vanguard Group Inc | 773702 | 5.22% | 9657 | 1.26% |
| 2024-03-31 | Morgan Stanley | 701732 | 4.73% | 216639 | 44.66% |
| 2024-03-31 | Renaissance Technologies Llc | 559817 | 3.78% | -4512 | -0.80% |
| 2024-03-31 | Boothbay Fund Management, Llc | 502174 | 3.39% | -7348 | -1.44% |
| 2024-03-31 | Acadian Asset Management Llc | 421427 | 2.84% | 86436 | 25.80% |
| 2024-03-31 | Capital Management Corp /Va | 364025 | 2.46% | 8491 | 2.39% |
About
Anika Therapeutics, Inc. is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company's main focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management, Regenerative Solutions, Sports Medicine and Arthrosurface Joint Solutions, and its products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika Therapeutics was founded in 1992 and is headquartered in Bedford, MA.
Address:32 Wiggins Avenue
Website:http://www.anikatherapeutics.com
Market Movers